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Abstract
Background: Acetaminophen (AAP) is widely prescribed for treatment of mild pain and fever in western countries. It is
generally considered a safe drug and the most frequently reported adverse effect associated with acetaminophen is
hepatotoxicity, which generally occurs after acute overdose. During AAP overdose, encephalopathy might develop and
contribute to morbidity and mortality. Our hypothesis is that AAP causes direct neuronal toxicity contributing to the general
AAP toxicity syndrome.
Methodology/Principal Findings: We report that AAP causes direct toxicity on rat cortical neurons both in vitro and in vivo
as measured by LDH release. We have found that AAP causes concentration-dependent neuronal death in vitro at
concentrations (1 and 2 mM) that are reached in human plasma during AAP overdose, and that are also reached in the
cerebrospinal fluid of rats for 3 hours following i.p injection of AAP doses (250 and 500 mg/Kg) that are below those
required to induce acute hepatic failure in rats. AAP also increases both neuronal cytochrome P450 isoform CYP2E1
enzymatic activity and protein levels as determined by Western blot, leading to neuronal death through mitochondrial–
mediated mechanisms that involve cytochrome c release and caspase 3 activation. In addition, in vivo experiments show
that i.p. AAP (250 and 500 mg/Kg) injection induces neuronal death in the rat cortex as measured by TUNEL, validating the
in vitro data.
Conclusions/Significance: The data presented here establish, for the first time, a direct neurotoxic action by AAP both in
vivo and in vitro in rats at doses below those required to produce hepatotoxicity and suggest that this neurotoxicity might
be involved in the general toxic syndrome observed during patient APP overdose and, possibly, also when AAP doses in the
upper dosing schedule are used, especially if other risk factors (moderate drinking, fasting, nutritional impairment) are
present.
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Introduction
Acetaminophen (paracetamol; AAP) is considered a non-
steroidal anti-inflammatory (NSAID) drug, even though in clinical
practice and in animal models it shows little anti-inflammatory
activity [1]. However, like NSAIDs, AAP is used to treat pain and
fever and it has become one of the most popular ‘over-the-counter’
non-narcotic analgesic agents. For instance, this compound has
been taken, at least once, by more than 85% of children under the
age of 91 months in the UK [2]. In the US, about 79% of the
general population regularly takes AAP [3], including more than
35% of pregnant women [2]. The most frequently reported
adverse effect associated with AAP is hepatotoxicity, which occurs
after acute over dosage (usually doses greater than 10 g are
needed) [4] and, less frequently, during long term treatment with
doses at the higher levels of the therapeutic range [5] or in the
presence of precipitating factors like fasting, nutritional impair-
ment or alcohol intake [4]. Besides hepatic toxicity, no AAP toxic
actions have been described in the nervous system, although it is
well known that AAP crosses the blood-brain barrier both in
rodents and humans [6]. Acetaminophen is mainly metabolised in
the liver via conjugation with glucuronic acid and sulphate and
then excreted, but, a small fraction is metabolised by cytochrome
P-450 [7,8] forming a chemically reactive metabolite, n-acetyl-p-
benzoquinone imine (NAPQI), which reacts with GSH to form a
non-toxic conjugate that will be excreted. Once GSH is exhausted,
NAPQI binds to cellular proteins, including mitochondrial
proteins, leading to hepatocellular death [9]. It has also been
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15360described that CYP2E1 is also expressed in the brain [10],
suggesting that AAP might be metabolised by neurons producing
the toxic metabolite NAPQI, which would lead to neurotoxicity.
Although there is a previous report indicating that AAP
potentiates staurosporine-mediated toxicity in neuroblastoma
[11], information on direct AAP neurotoxicity has not been
described.
Mitochondria play a key role in regulating the apoptotic
mechanisms and also in some forms of cell death by necrosis
[12,13]. Calcium overload or free radical production induce the
mitochondrial inner membrane permeabilization (MIMP) that
promotes mitochondrial swelling, outer membrane rupture and
release of intermembrane proapoptotic proteins such as cyto-
chrome C (cyt C) and apoptosis inducing factor (AIF) to the
cytoplasm [14]. These factors also activate caspases and,
subsequently, caspase-activated DNase [15].
In this study, we have studied the effect of AAP on rat cortical
neurons in culture and report, for the first time, that this widely
used drug has a low but persistent toxicity on neurons through a
mitochondrial-dependent mechanism involving cyt C release and
caspase 3 activation. In addition, in vivo experiments in rats show
that CSF levels achieved following i.p. AAP injection are similar to
those drug concentrations that cause neuronal death in vitro and
also produce a time-dependent neuronal death in vivo as measured
by an increase in the number of TUNEL positive cells in the
cortex. These data suggest that neuronal toxicity might be
produced by APP, in addition to the well-known hepatic toxicity,
and that it might contribute to AAP overdose toxicity.
Results
AAP induces apoptotic neuronal death
To test the effect of AAP on rat cortical neurons viability, cells
were plated on poly-L-lysine-coated 24-culture plates and, after 7-
10 DIV, incubated with different AAP concentrations for 24 h or
with AAP 1 mM for 6, 12, 18 and 24 h. After the incubation
period, supernatants and cell lysates were collected and LDH
activity was measured. Cellular mortality was expressed as the
percentage of LDH released to culture medium. AAP induced an
increase in the percentage of LDH released that was time- and
concentration-dependent (Figures 1A and 1B). For the next in vitro
experiments, concentrations of AAP from 0.5 to 2 mM were
chosen. Neurons died either by apoptosis, necrosis or a mixture of
both types of death. To determine the type of AAP-induced
neuronal death, DNA fragmentation was studied. DNA from
vehicle-, staurosporine- (a well-known inducer of apoptosis used as
internal control) and AAP-treated rat cortical neurons was
extracted and samples were subjected to electrophoresis on
agarose gel. After staining with ethidium bromide, observation
under UV light showed the classical laddering pattern in AAP-
and staurosporine-treated cells, but not in vehicle-treated cells
(Figure 2A). This is consistent with AAP inducing apoptotic death
in these neurons. In another set of experiments, rat cortical
neurons (7-10 DIV) treated with AAP 0.5 and 1 mM for 24 hours
showed chromatin condensation and nuclear fragmentation, a
feature of apoptosis, whereas only round blue nuclei were observed
in vehicle-treated cells (Figure 2B).
Mitochondrial role in AAP-induced neuronal death
A role for mitochondria in AAP-mediated hepatic toxicity has
been proposed [9,16], so we explored whether AAP was able to
induce the release of cyt C from this organelle in rat cortical
neurons. As is shown in Fig. 3A, AAP at the concentration range
used (0.5 to 2 mM) was able to induce cyt C release from
mitochondria to neuronal cytosol that was accompanied by a
decrease in mitochondrial cyt C content (Figs. 3A, 3B). Caspase-3
activity, as executioner protease of neuronal death, was studied
[17,18]. Acetaminophen treatment of rat cortical neurons in
culture for 3, 6, 18 and 24 h induced caspase-3 activation that
reached maximum levels at 18 h after AAP treatment, decreasing
Figure 1. AAP reduces rat cortical neuron viability. (A) Time
course effect of AAP treatment (1 mM) on cellular viability expressed as
percentage of LDH released to culture medium. V stands for vehicle
(DMSO 1%)-treated cells. Data represent mean 6 SEM of 12
experiments. ***p,0.01, as compared to vehicle-treated cells.
(B) Concentration-response effect of AAP on rat cortical neuron viability
24 h after treatment. V stands for vehicle (DMSO 1%)-treated cells. Data
represent mean 6 SEM of 12 experiments. *p,0.05 and ***p,0.01, as
compared to vehicle-treated cells.
doi:10.1371/journal.pone.0015360.g001
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neurons with the mitochondria permeability transition blocker
bongkrekic acid (2 to 20 mM) markedly decreased both AAP-
induced toxicity (Figure 4A) and caspase 3 activation (Figure 4B).
Considering all these data as a whole indicates that AAP induces
apoptosis in rat cortical neurons in culture and that mitochondria
play a prominent role in this death.
Acetaminophen induces neuronal death through free
radical production
N-Acetyl cysteine (NAC) increases intracellular glutathione and
is the drug of choice to treat AAP-induced liver toxicity [19,20].
Since the mechanism of action of this antioxidant is mainly related
to maintaining GSH levels in most mammalian cells [11,21], we
focused our interest on the effect of AAP on GSH levels in cortical
neurons. Quantification of total GSH content, in vehicle- and
AAP-treated cells for 18 h, showed that AAP reduced GSH levels
to 50% of control values in a concentration-dependent manner
(Figure 5A). This toxic effect was prevented either by the presence
of 100 mM NAC or by the CYP2E1 inhibitor disulfiram (TTD;
0.1 mM), which restored GSH content to vehicle-treated levels
(Figure 5A).
It has also been described that a decrease in GSH levels might
be related to an increase in reactive oxygen species (ROS)
production [11,21] that can activate different death signalling
pathways in neuronal tissues [22]. We thus decided to study ROS
production in AAP-treated cortical neurons. Cells were treated
with AAP at different concentrations for 18 hours and then the
rate of ROS production was monitored using the fluorescent dye
CM-H2-DCFDA. The results showed that AAP increased the rate
Figure 2. AAP induces apoptotic death in rat cortical neurons. (A) DNA degradation laddering pattern observed in rat cortical neurons after
treatment with AAP 0.5, 1 and 2 mM or staurosporine (St), used as a positive control, for 24 h. Vehicle-treated cells (DMSO 1%; V) did not show DNA
degradation. (B) Hoechst 33342 staining of cortical neuron nuclei treated with vehicle (DMSO 1%; upper panel), AAP 0.5 mM (middle panel) or AAP
1 mM (lower panel) for 24 h. Arrows show fragmented chromatin. Images are representative of one experiment repeated 3 times with similar results.
doi:10.1371/journal.pone.0015360.g002
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PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e15360Figure 3. Lost of neuronal cells induced by AAP is mediated by activation of intrinsic apoptotic pathway. (A) Left. Cytochrome c (Cyt c)
release from mitochondria to cytosol 24 h after AAP-treatment. Cells were treated with vehicle (DMSO 1%; V) or AAP at 0.5 (A0.5), 1(A1) or 2 (A2) mM
for 24 h and the cytosolic fraction was obtained. a-Tubulin (a-tub) was used as cytosolic protein loading control. Right. Densitometric analysis of Cyt c
related to a-tubulin (a-tub.) protein levels detected in cytosolic fraction. Data are expressed as mean 6 SEM of 3 independent experiments.
***p,0.001 as compared to vehicle-treated cells. (B) Left. Same experiment as in (A), but Cyt c mitochondrial content was determined. COX-IV was
used as mitochondrial protein loading control. Right. Densitometric analysis of Cyt c related to COX-IV protein levels detected in mitochondrial
fraction. Data are expressed as mean 6 SEM of 3 experiments. ***p,0.001 compared to vehicle-treated cells. (C) Time-course of caspase 3 activaty
induced by AAP. Cortical neurons were incubated with vehicle (DMSO 1%; N), AAP 1 mM (%) or AAP 2 mM (&). After different time periods, cell
lysates were obtained and caspase 3 activity determined as indicated in Material and Methods. Data represent mean 6 SEM of 12 independent
experiments. *p,0.05; **p,0.01; *** p,0.001 as compared to vehicle-treated cells. When not shown, SE bars were smaller than the symbol size.
doi:10.1371/journal.pone.0015360.g003
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(Figure 5B). To determine if this increase in ROS production
was related to AAP-induced CYP2E1 activity and caused a
decrease in GSH levels, we studied the effect of NAC and of the
CYP2E1 inhibitor TTD. Pre-treatment of cortical neurons with
NAC (100 mM) or TTD (0.1 mM) markedly reduced AAP(2 mM)-
induced ROS generation (Figure 5B). These results suggest that
ROS generation, through decreasing GSH levels, plays a key role
in the mechanism by which AAP induces rat cortical neuronal
death.
To analyse whether metabolism through CYP2E1 was involved
in the AAP toxicity mechanism, we determined the effect of TTD
on AAP-induced neuronal death. The results showed that TTD
markedly prevented AAP toxic effect on neuronal viability,
decreasing cellular death to an extent similar to that obtained
with NAC treatment (Figure 5C). These results suggest that
chemically reactive AAP metabolites and GSH depletion play a
central role in the AAP neurotoxicity mechanism.
AAP metabolism by CYP2E1 plays a key role in neuronal
toxicity
It is well-known that AAP is mainly metabolised via conjugation
with glucuronic acid and sulphate and then excreted, but a small
fraction of AAP is metabolised by the cytochrome P-450 isoform
CYP2E1, forming a highly chemically reactive metabolite,
NAPQI [8,23]. For this reason, we decided to study CYP2E1
enzymatic activity in rat cortical neurons. In vehicle-treated
neurons, low levels of CYP2E1 activity were detected (Figure 6A).
However, AAP treatment for 18 h increased CYP2E1 activity in a
concentration-dependent manner, indicating that this pathway for
the metabolism of AAP was increased in cortical neurons
(Figure 6A). In addition, AAP induced an increase in CYP2E1
expression as indicated by the rise in CYP2E1 protein levels
(Figure 6B). Blocking the mitochondrial permeability transition
using bongkrekic acid prevented an AAP-mediated increase in
CYP2E1 expression (Figure 6C).
In vivo toxicity of AAP on cortical neurons
Next, we explored whether AAP concentrations that produced
neuronal death in vitro could be achieved in the CSF of rats
following AAP administration, and whether it would cause
neuronal death. To fulfil this aim, we injected AAP (250 and
500 mg/Kg) i.p. to rats and measured AAP plasma and CSF levels
at different times after injection.
We found that one hour after injection, AAP plasma levels
reached 1 and 2 mM for i.p. injections of 250 and 500 mg/Kg
respectively. These levels remained elevated at 3 h after injection
(0.6 and 1.1 mM respectively), decreasing to basal levels 6 h after
injection (Figure 7A). Cerebrospinal fluid levels followed this
pattern but at slightly higher concentrations (1 and 3 mM for i.p.
injections of 250 and 500 mg/Kg) (Figure 7B), according to the
well-known ability of AAP to cross blood-brain barrier [24]. These
data show that, at least for 3 h, AAP levels that were toxic to rat
cortical neurons in vitro were achieved in rat CSF following AAP
i.p. administration. When the effect of the AAP i.p. injection
(250 mg/Kg and 500 mg/Kg) on rat brain cortex neurons was
explored, an increase in the number of TUNEL positive neurons
Figure 4. Bongkrekic acid (BA) prevents AAP-induced neuronal
death. (A) BA, by inhibiting mitochondrial permeability transition,
markedly reduced AAP-mediated toxicity on rat cortical neurons in a
concentration-dependent manner. Cells were treated with vehicle
(DMSO 1%; V) or AAP 2 mM (A2) in the presence or absence of BA at
different concentrations for 24 h and the percentage of LDH released to
culture medium was quantified. Data represent mean 6 SEM of 9
independent experiments. *** p,0.001 as compared to A2-treated
cells. (B) BA prevents caspase 3 activation induced by AAP. Cells were
treated with vehicle (DMSO 1%; V) or AAP 2 mM (A2) in the presence or
absence of BA 20 mM (A2+ BA20) for 18 h and caspase 3 activity in total
lysates was determined. Data represent mean 6 SEM of 12 independent
experiments. *** p,0.001 as compared to A2-treated cells.
doi:10.1371/journal.pone.0015360.g004
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tion-dependent neuronal toxicity in that area of the brain (Figure 8)
Next, we explored whether a transient exposure to AAP for 3 h,
followed by drug withdrawal, was enough to induce cellular death
in vitro. This experimental protocol would mimic what happens
with CSF AAP levels in vivo following AAP i.p. injection. We found
that a single 3-h exposure to AAP (1 and 2 mM) induced a small
but progressive neuronal death in vitro that affected as many as
10% of the neurons 96 h after AAP treatment (Figure 9A).
Accordingly, caspase 3 activity was found to increase in cortical
neurons transiently exposed to AAP (1 and 2 mM) (Fig. 9B).
Discussion
Our experiments show that AAP, a drug that is widely used
(more than 70% of the population in western countries has taken
at least once AAP and a relevant percentage takes the drug
chronically) as a mild pain reliever and antithermic [3], has direct
neurotoxic effects on rat brain neurons both in vitro and in vivo.
Moreover, these toxic effects are produced in vitro at concentra-
tions that are achieved transiently (for about 3 h) in rat CSF
following AAP i.p. injection. It is important to note that in vitro
transient exposure (3 h) of cultured rat cortical neurons to AAP
concentrations, similar to those achieved in CSF following AAP
i.p. injection (0.5 to 2 mM), produces an increase in caspase 3
activity that leads to a small but progressive neuronal death that
increases with time. This toxic effect seems to be mediated by AAP
metabolism by the cytochrome P-450 CYP2E1 isoform that
generates a highly reactive metabolite NAPQI. This highly
reactive compound is conjugated with GSH, producing a decrease
in GSH levels in neurons that leads to neuronal death.
Accordingly, co-treatment of neurons in culture with NAC, which
restores GSH levels, prevents neuronal death.
We have found that AAP, at the doses used (above 1 mM in vitro
and 250 mg/Kg in vivo), is neurotoxic, both in vivo and in vitro, to
rat cortical neurons. This is the first time that this toxic AAP effect
on neurons has been described. It had previously been described
that AAP 1 mM did not affect the total number of mesencephalic
neurons for 48 h [25], whereas we have detected a loss in cortical
neuronal viability at 24 h. Differences with our results might be
explained by the different kind of neurons studied. On the other
hand, Bisaglia et al. have shown that AAP (100 mM) protects
hippocampal neurons and PC12 cultures from amyloid beta-
peptides [26]. Moreover, AAP (100 mM) pre-treatment also
prevented menadione-induced neurotoxicity [27] and AAP
(100 mg/kg) protected against oxidative neurotoxicity in vivo at
4 h after its administration every hour for 3 hours [28]. Locke et
al. have shown that AAP (100 mM) protected C. elegans dopamine
neurons from 6-OHDA exposure [29]. However, when AAP was
Figure 5. Redox status of rat cortical neurons. (A) Neuronal
glutathione levels were decreased by treatment with 1 mM (A1) or
2 mM (A2) AAP in a concentration-dependent manner whereas co-
treatment with either N-acetylcysteine (NAC; 100 mM) or disulfiram
(TTD; 0.1 mM) completely restored glutathione content to basal levels. V
stands for vehicle (DMSO 1%)-treated cells. Data represent mean 6
SEM of 9 independent experiments. *** p,0.001 as compared to
vehicle-treated cells). (B) AAP 0.5 (A0.5), 1 (A1) and 2 mM (A2) induced a
dose-dependent increase in the rate of reactive oxygen species (ROS)
production, that was prevented by both N-acetylcysteine (NAC;
100 mM) and disulfiram (TTD, 0.1 mM). V stands for vehicle (DMSO
1%)-treated cells. Data represent the mean 6 SEM of 9 independent
experiments. ***, p,0.001 as compared to vehicle-treated cells (V);
###,p ,0.001 compared to AAP 2 mM (A2). (C) NAC (100 mM) as well
as TTD (0.1 mM), by reducing free radical production, markedly reduce
AAP-mediated toxicity on rat cortical neurons. Cortical neurons were
incubated with vehicle (DMSO 1%; V) or AAP 2 mM (A2) alone or in the
presence of NAC 100 mM (A2+NAC) or TTD 0.1 mM (A2+TTD) for 24 h
and percentage of LDH released to the culture medium was
determined. Data represent the mean 6 SEM of 9 independent
experiments. ***, p,0.001 as compared to AAP 2 mM-treated cells.
doi:10.1371/journal.pone.0015360.g005
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application and was lost when higher concentrations (2 and
9.2 mM) were used. Moreover, it has been recently shown that
intraperitoneal administration of AAP (5–100 mg/kg) seems to
have protective effects on oxidative stress-induced brain toxicity by
inhibiting free radical production [30]. However, no beneficial
Figure 6. Free radicals generated from AAP metabolism, through CYP2E1 activity, play a central role in AAP-induced neuronal
death, in a mechanism dependent on mitochondrial permeability transition. (A) AAP increases CYP2E1 activity in a concentration-
dependent manner in rat cortical neurons. Cells were treated with vehicle (DMSO 1%; V) or AAP 0.5 (A0.5), 1 (A1) and 2 mM (A2)) for 18 h and total
lysates were obtained. CYP2E1 activity was quantified as nmol p-nitrophenol transformed per milligram of protein in total lysates. Data represent the
mean 6 SEM of 9 independent experiments. *** p,0.001 as compared to vehicle-treated cells (V). (B) AAP increases CYP2E1 protein levels in a time-
and concentration-dependent manner. Left. CYP2E1 expression detected in total lysates obtained from cells treated with vehicle (DMSO 1%;V )o r
AAP at 1 mM (A1) or 2 mM (A2) for 3, 6 and 18 h. a-Tubulin (a-tub) was used as protein loading control. Right. Densitometric analysis of CYP2E1
related to a-tubulin (a-tub.) protein levels detected in total lysates. Data are expressed as mean 6 SEM of 3 independent experiments. *p,0.05;
**p,0.01; ***p,0.001 compared to vehicle-treated cells. (C) Bongkrekic (BA), by inhibiting mitochondrial permeability transition, prevents AAP-
induced CYP2E1 induction. Left. CYP2E1 expression detected in total lysates obtained from cells treated with vehicle (DMSO 1%; V) or AAP 1 mM ()
and 2 mM in the absence (A1; A2) and the presence of BA 20 mM (A1BA; A2BA) for 18 h. a-Tubulin (a-tub.) was used as protein loading control. Right.
Densitometric analysis of CYP2E1 related to a-tubulin (a-tub.) protein levels detected in total lysates. Data are expressed as mean 6 SEM of 3
independent experiments. *p,0.05 as compared to A1-treated cells;
##,p ,0.01 as compared to A2-treated cells.
doi:10.1371/journal.pone.0015360.g006
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or 500 mg/Kg. In contrast,On the other hand, 1 mM AAP was
significantly toxic to stage I HUCB-NSCs, in agreement with our
observations [31].
To summarise, it seems that AAP concentrations up to 100 mM
or AAP doses up to 100 mg/Kg prevent ROS production and
citotoxicity, but higher doses do not. Furthermore, several recent
studies have shown the protective effects of antioxidants on hepatic
failure induced by AAP overdose [32–34], indicating that high
AAP concentrations, far from protecting cells from ROS toxicity,
actually contribute to ROS production. In agreement with these
data, we have shown that AAP increases ROS production in a
concentration-dependent manner 18 h after treatment.
Acetaminophen is mainly metabolised, in the liver, via
conjugation by sulphotransferase and UDP-glucuronosyltransfer-
ase and then excreted, but a small fraction of it is metabolised by
CYP2E1 [7,35]. This P-450 isoenzyme is very abundant in the
liver [36] and is also expressed in the brain [10], although at much
lower levels, where it seems to play an important role in
metabolizing some compounds like AAP and ethanol. CYP2E1
is the most important P-450 isoenzyme involved in AAP
metabolism, although other isoforms like CYP1A2 or CYP3A
might also be involved [37]. It has long been known from the work
of the Brodie group [38,39] that induction of P-450 enhances
AAP-mediated liver toxicity [36]. Acetaminophen metabolism by
CYP2E1 produces a chemically reactive metabolite, NAPQI, that
might bind to sulfhydryl groups in cellular proteins, including
mitochondrial proteins, inducing oxidative stress and leading to
cellular damage and death [40,41]. Generally, NAPQI reacts with
GSH to form a non-toxic conjugate that will be excreted [42,43].
Excess NAPQI production, due to increased AAP levels and
substrate-induced CYP2E1 stabilisation [36], leads to a reduced
GSH content in cortical neurons in culture in a concentration -
dependent manner.
Rats exposed to APP have shown unchanged levels of AAP in
the brain and kidneys, levels similar to those found in other tissues
[6]. These authors discarded a possible toxic effect of AAP in those
tissues due to the low activity of the cytochrome P-450 system, as
determined by the lower covalent binding in the brain and kidneys
when compared to the liver, but they did not study the effect of
AAP on renal or brain cells viability directly [6]. Later studies
showed that AAP can induce renal tubular damage and acute
renal failure in the absence of liver injury by a mechanism related
to NAPQI production through cytochrome P-450 activation and
glutathione depletion, which would lead to NAPQI binding to
cellular proteins [44–47], despite the low levels of AAP-glutathione
conjugate found in kidney by Fisher and co-workers. Our
experiments show that cortical neurons not only express the 2E1
isoform of cytochrome P-450, but also that AAP enhances its levels
and activity after 18 h of treatment. Since AAP is found unaltered
in the brain and AAP increases CYP2E1 expression and activity,
AAP could induce cortical neuron apoptosis due to increased local
NAPQI production through CYP2E1 enzymatic activity. In
addition, TTD, an inhibitor of the 2E1isoform of cytochrome P-
450, significantly reduced AAP-induced neuronal death, suggest-
ing a role for this enzymatic activity in the mechanism involved in
AAP-mediated neuronal death. Moreover, an increase in AAP-
mediated ROS levels could also contribute to neuronal damage.
The combination of NAPQI, which could damage mitochondria,
and ROS, contributing to cyt C release, would activate the
intrinsic death pathway leading to caspase 3 activation and
apoptotic death.
GSH is a thiol-containing coenzyme that plays a relevant role in
several redox reactions in the body, including the maintenance of
the thiol properties of reduced coenzyme A, cysteine and vitamins
C and E. GSH is the main cellular antioxidant, and is found at
concentrations of between 1 and 10 mM in most mammalian cells,
including neurons. Its depletion could induce accumulation of
NAPQI, which might mediate the toxic effect observed with AAP
treatment through the mechanisms described above. According to
this proposed mechanism, NAC, a drug that increases intracellular
glutathione levels, prevents AAP-induced neuronal death. The
mechanism involved is similar to that observed in the liver, but this
is the first time that it has been described in neuronal cells, both in
vitro and in vivo, following AAP treatment.
Although it is generally assumed that LDH efflux in vivo
represents necrotic cell death, in cell culture, quantification of
Figure 7. Time-course of rat plasma and cerebrospinal fluid
(CSF) AAP levels. (A) Time-course of AAP plasma levels measured
after intraperitoneal administration of vehicle (H2O:PEG, 1:1; N), AAP
250 mg/kg (%) and 500 mg/kg (&). Data represent mean 6 SEM of 6
animals. **p,0.01; ***p,0.001 as compared to vehicle-treated cells.
(B) Time-course of AAP CSF levels measured after intraperitoneal
administration of vehicle (H2O:PEG, 1:1; N), AAP 250 mg/kg (%) and
500 mg/kg (&). Data represent mean 6 SEM of 6 animals. **, p,0.01;
*** p,0.001 as compared to vehicle treated cells.
doi:10.1371/journal.pone.0015360.g007
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PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e15360Figure 8. Acetaminophen toxicity in vivo. A. Brain cortex tissue slices (5 mM thick) from vehicle (V; H2O:PEG, 1:1), AAP (250 mg/Kg i.p.) and AAP
(500 mg/Kg i.p) injected animals obtained 24 h post-injection, were double-stained with Dapi to identify nuclei, apoptotic neurons were labelled
using TUNEL as indicated in Material and Methods. An overlay of both signals (Ovl) is also presented. Arrows indicate cells showing an overlay of
TUNEL and Dapi signals. The figure shows a representative experiment that was repeated 3 times with similar results. B. Quantification of damaged
neurons. Data represent the percentage of TUNEL positive cells related to total Dapi stained cells. For quantification, a total of 12 image fields from2
different animals were used for each condition. The average number of cells per field was 79.162.8 (mean 6 SEM). For each field, the percentage of
TUNEL positive neurons was determined. The total number of neurons (100% of the y axis) counted for each experimental condition was: 990 for
vehicle; 1050 for AAP (250 mg/Kg)-treated rats and 920 for AAP (500 mg/kg)-treated rats. Data represent mean 6 SEM of the percentage of TUNEL
positive cells in 12 image fields from 2 different animals for each condition. ***p,0.001 as compared to vehicle treated animals.
doi:10.1371/journal.pone.0015360.g008
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PLoS ONE | www.plosone.org 9 December 2010 | Volume 5 | Issue 12 | e15360LDH, rather than necrotic death, represents cellular death in
general. In necrotic death in vivo, cytoplasmic membrane lyses and
intracellular content is released, resulting in inflammation [48],
whereas in apoptosis, the cellular contents are safely sealed within
the dying cells until phagocytosis intervenes. However, in culture
cells the phagocytic step after apoptosis does not occur and
apoptotic cells undergo secondary necrosis, releasing their contents
into the surrounding medium [49]. Acetaminophen-induced
neuronal death exhibits the hallmarks of apoptotic death, such
as DNA fragmentation and degradation, showing a ladder-type
image (Figure 2A), suggesting activation of the mitochondrial
pathway and ROS production in AAP-mediated neuronal toxicity.
Moreover, the observed cyt C release, ROS generation and
activation of caspase 3 in response to AAP support this point. In
addition, mitochondrial permeability transition seems to play a
central role in this mechanism since bongkrekic acid, an inhibitor
of mitochondrial adenine nucleotide translocase [50], prevents
both caspase 3 activation and the loss of neuronal viability.
These neurotoxic AAP in vitro actions can be also found in vivo.I t
is known that AAP crosses the blood-brain barrier both in humans
and rodents [24], but it is important to note that the data
presented here show that, following i.p. AAP injection, there is an
increase in CSF drug levels that reaches transiently, for about
3 hours, the AAP concentrations that produce rat cortical
neuronal death in vitro. Accordingly, an increase in the number
of TUNEL positive neurons, suggestive of neuronal death, can be
observed in rat brain cortex following AAP i.p. injection. On the
other hand, transient exposure of cultured cortical neurons to the
same concentrations achieved in CSF following AAP i.p. injection
induces a delayed neuronal death.
It has been previously described that AAP overdose is the most
common cause of acute liver failure (ALF) in western countries
[51,52]. One of the main causes of morbidity and mortality in
ALF is encephalopathy [53]. Encephalopathy has been related to
the ‘‘glutamine hypothesis’’ wherein detoxification of ammonia by
astrocytes leads to conversion of glutamate to glutamine, which
can increase tissue osmolarity and cause oedema [54,55].
Alternatively, cerebral oedema may also develop from failure of
intracellular vascular autoregulation with resultant increases in
brain water and brain volume [54,56]. Despite these indirect
actions, no evidence of a direct action of AAP on neuron viability
has been described.
Furthermore, it was recently found that AAP overdose
(400 mg/kg, i.p.) reduces creatine kinase activity (CK) in the
cerebellum and hippocampus but not in other brain areas [57].
CK catalyses ATP regeneration from ADP and decreased activity
has been associated with neurodegenerative pathways [58,59]. It
has been postulated that CK inhibition is probably involved in the
pathogenesis of hepatic encephalopathy [57]. Taken together,
these results suggest that the neurotoxic action of AAP described
here is relevant in vivo, in the rat, and that it might happen in other
mammalian species including humans.
In summary, our data indicate that, in rats, AAP produces
neuronal death of cortical neurons, both in vivo and in vitro, at the
same concentration range. This neurotoxic action seems to be
mediated by activation of the neuronal cytochrome P450 isoform
CYP2E1 and generation of the toxic metabolite NAPQI, which
exhausts GSH levels leading to neuronal death through mito-
chondrial–mediated mechanisms. This newly described effect of a
very widely used drug like AAP suggests that this neurotoxic effect
might contribute to AAP overdose—mediated toxicity. Further
studies should be conducted to determine if this neurotoxic action
of AAP is a drug-class effect shared by other NSAIDs or by COX-
inhibiting drugs.
Materials and Methods
Animal handling. Ethics statement
All animals were treated and killed in accordance with
European Union (2003/65/CE) guidelines on the use of
laboratory animals. Protocol for animal handling and sacrifice
was approved by the Comite ´d eE ´tica de Experimentacio ´n Animal
of the Universidad de Castilla-La Mancha.
Figure 9. Toxicity of transient exposure to AAP. A. Cortical
neurons were incubated with vehicle (H2O:PEG, 1:1;N), AAP 1 mM (%)
and AAP 2 mM (&) and 3 h later, the medium containing the drug was
removed (AAP withdrawal) and replaced with medium lacking the drug,
mimicking what happens in vivo. The percentage of LDH released was
measured to study cumulative toxicity at different times. Data represent
mean 6 SEM of 9 independent experiments. **p,0.01; *** p,0.001 as
compared to vehicle treated cells. B. Same protocol as in A, but caspase
3 activity was determined at 18 h after treatment. Data represent mean
6 SEM of 9 independent experiments. ***p,0.001 as compared to
vehicle-treated cells (v).
doi:10.1371/journal.pone.0015360.g009
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Primary cultures of brain cortical neurons were essentially
prepared as described previously [60]. After isolation, the cells
were resuspended in serum-free Neurobasal medium supplement-
ed with B27, containing 2 mM L-glutamine, penicillin (20 units/
ml) and streptomycin (5 mg/ml), and plated on poly-L-lysine-
coated 24- or 6-well culture plates or on poly-L-lysine-coated glass
coverslips. The combination of Neurobasal, B27 and the lack of
serum minimised glial proliferation. The culture contained around
95% pure neurons when determined by glial fibrillary acidic
protein (GFAP) and neuronal-specific (NeuN) antigen immuno-
staining (data not shown). Cells were maintained at 37uCi na
saturated humidity atmosphere containing 95% air and 5% CO2
and used for experiments after 7–10 days in vitro (DIV).
Viability experiments
After 7-10 DIV neurons were treated with vehicle (DMSO 1%)
or AAP at different concentrations for the times indicated.
Supernatants were then collected and cells were washed with
PBS and lysed with 0.9% Triton X-100 (v/v) in saline. LDH
activity, used as an index of neuronal death, released to culture
media, as well as LDH present in lysates, was measured
spectrophotometrically at 490 nm on a 96-well plate reader using
the Cytotox 96 Kit (Promega) as previously described [61].
Mortality was expressed as a percentage of LDH released.
Hoescht 33342 staining
Cells were plated on poly-L-lysine-coated glass coverslips and,
after 7-10 DIV, treated with vehicle, AAP 0.5 and 1 mM for 24 h.
After the incubation period, the cells were loaded with Hoescht
33342 by incubation (1 mM for 5 min at 37uC) in Krebs-Henseleit
solution (with the following composition in millimoles/Liter: NaCl
140, KCl 5.9, MgCl2 1.2, HEPES 15, glucose 10, CaCl2 2.5,
pH 7.4). The cells were then washed twice with Krebs-Henseleit
solution and fluorescence was observed using a 350-nm excitation
filter and a 450-nm emission filter in a Nikon Diaphot inverted
microscope equipped with a 75W Xenon lamp and a Nikon 40X,
1.3 numerical aperture, epifluorescence oil immersion objective.
Images were taken with a CCD camera using commercial software
(Metamorph, Universal Imaging Corporation, Silicon Valley, CA,
USA).
DNA fragmentation analysis
DNA fragmentation was studied as previously described [62].
The cells were plated on poly-L-lysine-coated 6-well culture plates
and, after 7-10 DIV, treated with vehicle (DMSO 1%),
staurosporine (500 nM) or AAP at different concentrations.
Twenty four hours later, the cells were collected by scraping and
centrifuged at 8006g for 10 min. Pellets were washed twice with
PBS-MgCl2 5 mM and then resuspended in Lysis buffer (50 mM
Tris-HCl, 50 mM NaCl, 10 mM EDTA, 0.5% SDS pH 7.4)
containing 0.125% (w/v) proteinase K and maintained at 50uC
overnight. After centrifugation at 10,0006g for 10 min at 4uC,
fragmented DNA in the supernatant was extracted by adding a
mixture of phenol/chloroform/isoamyl alcohol (24:24:1) and
centrifuged at 10,0006g for 10 min at 4uC. Fragmented DNA
in the aqueous phase was precipitated by adding 3 M sodium
acetate and 800 ml of absolute ethanol and then isolated by
centrifugation at 10,0006g for 20 min. The DNA pellet was
dissolved in 25 ml of a 10 mM Tris-HCl, pH 7.4 solution
containing 1 mM EDTA. The DNA samples were subjected to
electrophoresis on 1.5% agarose gel and then observed under UV
light after staining with ethidium bromide.
Subcellular fractionation
Cells were plated in poly-L-lysine-coated 6-well culture plates
and, after 7-10 DIV, treated with vehicle (DMSO 1%) or AAP at
0.5, 1 and 2 mM for 24 hours. Afterwards, the cells were washed
twice with PBS, scraped and collected by centrifugation at
1,5006g for 10 min. The cell pellets were resuspended in 200 ml
of extraction buffer (250 mM sucrose, 50 mM Tris-HCl, 1 mM
EGTA, 2.5 mM EDTA, 50 mMN a 3VO4, 1 mM DTT, 0.1 mM
PMSF, 40 mg/ml aprotinine, 20 mg/ml leupeptine; pH 7.4) and
homogenised with a pellet pestle (15 strokes) and, after 15 min on
ice, centrifuged at 9006g for 5 min at 4uC. The pellets, containing
nuclei and intact cells, were discarded and the supernatants were
centrifuged at 20,0006g for 30 min at 4uC. The supernatants, i.e.
cytosolic fractions, were removed and stored at 280uC until
analysed by gel electrophoresis. Pellets containing mitochondria
were resuspended in 50 ml of extraction buffer, homogenised with
a pestle (5 strokes) and then centrifuged at 20,0006g for 60 min at
4uC. The supernatants, i.e. mitochondrial fractions, were removed
and analysed by gel electrophoresis.
To obtain whole lysates, cells were plated on poly-L lysine
coated 6-well culture plates and, after 7-10 DIV, treated with
vehicle (DMSO 1%) or AAP at 1 and 2 mM for 3, 6 and 18 h, or
with vehicle (DMSO 1%) or AAP at 1 and 2 mM in the presence
or absence of bongkrekic acid (BA) 20 mM for 18 h. Afterwards,
the cells were washed twice with PBS and lysed in lysis buffer
containing 25 mM Tris-HCl, 25 mM NaCl, 5 mM DTT, 0.1%
deoxycholic acid and 1% Triton x-100. Extracts were then
centrifuged at 5,0006g for 10 min at 4uC and supernatants (total
lysates) were removed and stored at 280uC until analysed by gel
electrophoresis.
Western Blot Analysis
Western blot analysis was performed as previously described
[63]. Protein samples (30 mg) were loaded on 15% PAGE-SDS
and transferred onto nitrocellulose membranes. Membranes were
blocked in PBS-Tween 20 (0.1%) containing 5% non-fat dry milk
and 0.1% BSA for 1 h at 4uC and incubated with CYP2E1
polyclonal antibody (1:1,000) (Abcam, Cambrige, UK), anti-
cytochrome c polyclonal antibody (1:1,000) (BD Biosciences,
Madrid, Spain), anti-a-tubulin polyclonal antibody (1:2,000)
(Merck Chemicals Ltd., Barcelona, Spain) or anti-OxPhos
Complex IV subunit IV (COX-IV) monoclonal antibody
(1:1,000) (Cell Signalling Technology, Barcelona, Spain) overnight
at 4uC. Afterwards, the blots were washed with PBS-Tween 20
(0.1%) and incubated with Horse Rabbit Peroxidase conjugated
(HRP)-anti-mouse IgG (1:10,000) (Jackson ImmunoResearch
Laboratories, Madrid, Spain) for 2 h at 4uC. Immunoreactive
bands were observed using an enhanced chemiluminiscence
system (ECL; GE Healthcare, Barcelona, Spain).
Densitometric analysis of immunoreactive bands was performed
by using the ImageQuant 5.2 program (GE Healthcare, Barcelona,
Spain).Theresults wereexpressedastheratioofoptical densitiesfor
CYP2E1(O.D.CYP2E1),cytochromec(O.D.cyt.C)and a-tubulin
(O.D. a-tub) or for COX-IV (O.D. COX-IV).
Caspase 3 activity
Caspase 3 activity was studied as previously described [64].
Cells were plated in poly-L-lysine-coated 6-well culture plates and,
after 7-10 DIV, treated with vehicle (DMSO 1%) or AAP 2 mM
for 3, 6, 18 and 24 h. Afterwards, the cells were washed twice with
cold PBS and lysed in Lysis buffer containing 100 mM Hepes
pH 7.4, 5 mM DTT, 5 mM EGTA, 0.04% Nonidet P-40, and
20% glycerol. Extracts were then centrifuged at 5,0006g for
10 min at 4uC. Cell extracts (40 mg of protein) were incubated in
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10 mM DTT) containing 50 mM fluorescent substrate Z-DEVD-
AFC at 37uC for 1 h. Cleavage of the AFC fluorophore was
determined in a spectrofluorometer at an excitation wavelength of
400 nm and fluorescence was detected at an emission wavelength
of 505 nm. Caspase 3 activity was expressed as units of
fluorescence/mg of protein/h.
Glutathione measurement
Glutathione levels were determined as previously described
[22]. Briefly, cells were plated in poly-L-lysine-coated 6-well
culture plates and, after 7-10 DIV, treated with vehicle (DMSO
1%) or AAP at 1 and 2 mM for 18 h. In another set of
experiments, cells plated in 6-well plates maintained for 7-10 DIV
were treated with vehicle (DMSO 1%) or AAP alone or in
combination with N-acetylcysteine (NAC) or disulfiram (TTD) for
18 h. Then, the cells were washed twice with cold PBS and
scraped in 1 ml of PBS. The cells collected were counted and then
centrifuged at 1,5006g for 10 min and the pellet was resuspended
in 5-sulphosalicylic acid (3.33%) containing 0.25 mM EDTA to
prevent glutathione (GSH) oxidation and to inhibit GSH-utilizing
enzymes. The tubes were frozen and thawed three times to break
the cells and release GSH. The lysates were then centrifuged at
10,0006g for 5 min at 4uC and the supernatants transferred to
eppendorf tubes kept on dry ice until assayed for glutathione
content. Glutathione measurements were performed as previously
described [65]. GSH reacts non-enzymatically with 5,59-dithiobis-
(2-nitrobenzoic acid) to generate oxidised glutathione (GSSG) and
the highly coloured 5-thio-2-nitrobenzoic acid (peak absorbance
420 nm); the GSSG that forms is back reduced to GSH by
glutathione reductase coupled to NADPH oxidation. In this
cycling assay, the rate of colour formation is linear in time and the
slope is directly proportional to total glutathione (GSH + GSSG;
GSt) concentration. Standards and cell lysates, assayed in
triplicate, were incubated in reaction buffer (0.125 M phosphate
buffer pH 7.5, containing 0.21 mM NADPH, 0.6 mM DTNB,
6.3 mM EDTA and 2 U glutathione reductase) at 37uC and
absorbance was measured every 15 s over 1 min at 420 nm.
Concentrations obtained were normalised by the number of living
cells after treatments. Although NAC contains a sulfhydryl group
that might react with 5,59-dithiobis-(2-nitrobenzoic acid) (DTNB) -
the color-generating reagent in the assay mixture - the enzymatic
cycling mediated by glutathione reductase provides the required
assay specificity to measure glutathione, and prevents the
interference from other compounds having the sulfhydryl group
[66]. In addition, GSH levels measured in cortical neurons treated
with vehicle or only with TTD showed no differences in GSH
content between vehicle- and TTD-treated neurons, confirming
that even though TTD is a substrate for glutathione reductase [67]
and is reduced to diethylsithiocarbamate, the method used was
specifically for measuring GSH.
Cytochrome P450 2E1 isoform activity
Cells were plated in poly-L-lysine-coated 6-well culture plates
and, after 7 DIV cells, treated with vehicle (DMSO 1%) or AAP at
0.5, 1 and 2 mM for 18 h. Then, the cells were washed twice with
cold PBS and scraped in 1 ml of PBS and collected by
centrifugation at 1,5006g for 10 min. Cell pellets were resus-
pended in 200 ml of extraction buffer (100 mM KH2PO4, pH 7.4)
and homogenised with a pellet pestle (Sigma) (30 strokes) and then
centrifuged at 10,0006g for 30 min at 4uC. Cell lysates (60 mg)
were incubated in reaction buffer (50 mM Tris buffer, pH 7.4,
containing 5 mM MgCl2, 0.5 mM NADPH and 0.5 mM
p-nitrophenol) at 37uC for 30 min. The reaction was stopped by
the addition of 0.6 N perchloric acid, and after precipitation of
proteins by centrifugation at 10,0006g for one minute at 4uC,
supernatants were mixed with 10 N NaOH. The absorbance was
measured at 535 nM [68]. Cytochrome P450 2E1 isoform
(CYP2E1) activity was expressed as nmoles of p-nitrophenol
transformed/mg of protein/h. The fact that CYP2E1 is
constitutively expressed in the brain and is induced by different
drugs, including AAP, [69,70] and that AAP is mainly metabolised
by the 2E1 isoform of cytochrome P-450 [7] suggests that the P-
450 enzymatic activity observed in treated neurons corresponds to
the CYP2E1isoform.
Free-radical production
Cells were plated in poly-L-lysine-coated glass coverslips and,
after 7 DIV, treated with AAP 0.5, 1 and 2 mM, alone or in
combination with either NAC or TD, for 18 h. To monitor free-
radical production, the cells were loaded by incubation with CM-
H2DCFDA (Molecular Probes; Barcelona, Spain) (10 mM for
30 min at 37uC) in Krebs-Henseleit solution as described
previously [71]. Images were taken with a CCD camera and
analysed using commercial software (Universal Imaging Corpora-
tion, Silicon Valley, CA, USA). Background was subtracted and
fluorescence was recorded using a 535-nm excitation filter and a
635-nm emission filter. Frames were recorded every 15 s over a
10-min period. Fluorescence data for each condition were fitted to
the equation y=a+bx, and the slope b was taken as an index of
the rate of superoxide production [22].
Quantification of AAP concentration in LCR and plasma
obtained from AAP-injected rats
Female Sprague-Dawley rats weighing 240–260 g were divided
into groups (6 to 8 animals each group) and injected intraperi-
toneally with vehicle (H2O:polyehylene glycol (PEG) 1:1) or AAP
at the doses of 250 or 500 mg/kg in 1 ml of (H2O:PEG 1:1). After
1, 3 or 6 h, the animals were anesthetised with halothane and 1 ml
of blood was obtained by intracardiac puncture. The blood was
mixed with 1% sodium citrate in saline and centrifuged (4,0006g,
10 min, 4uC) to obtain the plasma. Similarly, 100 ml of brain
cerebrospinal fluid (CSF) was obtained by cisternal punction.
Afterwards, the animals were killed by decapitation. Plasma and
brain cerebrospinal fluid samples were frozen at 280uC until
analysed.
Plasma and CSF AAP concentrations were measured using a
HPLC method described previously [72].
Immunohistochemical analysis of in vivo neuronal death
Paraffin-embedded rat frontal cortex sections (5 mm thick) were
deparaffinised, rehydrated, and subjected to high-temperature
antigen retrieval in 10 mmol/L sodium citrate buffer, pH 6. The
slices were incubated with 49, 6 diamidine-2-phenylindole (DAPI;
5 mg/ml) to identify nuclei. Apoptotic cells were identified by the
TUNEL technique (In Situ Cell Death Detection kit, fluorescein
labelled. Roche Diagnostics, Mannheim, Germany), used accord-
ing to the manufacturer’s instructions. The sections were analysed
using a Nikon inverted microscope (Nikon Eclipse TE-2000-S,
Birlingam, CA, USA) equipped with a 150 W Xenon lamp and a
100X, 1.3 numerical aperture, epifluorescence oil immersion
objective. The excitation wavelength was selected using a Life
Technologies monochromator (Omega Optical Inc, Brattleboro,
VT, USA) and the emission wavelength using a filter wheel (Sutter
Instruments, Novato, CA, USA). Images were taken using a digital
camera (ORCA II, Hamamatsu, Shizouka, Japan). The data were
analysed using commercial software (Metamorph, Universal
Acetaminophen Neurotoxicity
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wavelengths were used for each fluorescent dye: DAPI, ex:
350 nm, em: 450 nm. TUNEL, ex: 480 nm, em: 520 nm. Six
randomly selected image fields from the cortex of two different
animals were analysed for each experimental condition.
Analysis
Data are expressed as mean 6 SEM. Statistical analyses were
carried out using the one-way analysis of variance (ANOVA) and
the a posteriori Bonferroni’s t-test for multiple comparisons. P values
of less than 0.05 were considered significant (*p,0.05, **p,0.01,
***p,0.001). Statistical results are reported in the figure legends.
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